Anagenics Ltd
ASX:AN1
Prices of ASX stocks are not being updated. The latest AN1 price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Anagenics Ltd (AN1) under the Base Case is AUD per share. Compared with the last price of 0.005 AUD on Oct 14, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Anagenics Does
Anagenics Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-12-09. The principal activities of the Company include the development, distribution and sale of health, beauty and wellness products (Consumer health).
- Headquarters
- Australia AU
- IPO date
- Dec 9, 2005
Earnings Waterfall
Anagenics Ltd
What is the Intrinsic Value of one AN1 stock?
The intrinsic value for Anagenics Ltd (AN1) under the Base Case is AUD.
Is AN1 stock undervalued or overvalued?
Compared with the last price of 0.005 AUD on Oct 14, the stock appears .